Levofloxacina Mylan Generics Italia (Levofloxacin)

Levofloxacin exerts its antibacterial effect by inhibiting two essential bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are required for DNA supercoiling, replication, and transcription. By binding to them, levofloxacin prevents DNA unwinding and resealing, leading to interruption of bacterial DNA synthesis and ultimately bacterial cell death.

The dosage of Levofloxacina Mylan Generics Italia is individualized by the treating physician. The prescriber determines the appropriate strength, frequency, and duration based on the infection type, severity, patient age, renal function, and other clinical factors. Patients should follow the exact regimen provided on the prescription label.

Levofloxacin is classified as Pregnancy Category C, meaning risk cannot be ruled out and it should only be used if the potential benefit justifies the potential fetal risk. It is excreted in breast milk, so breastfeeding mothers should discuss alternatives with their healthcare provider. The prescriber will weigh risks and benefits for each individual case.

To request Levofloxacina Mylan Generics Italia, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team then replies with pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Levofloxacin belongs to the fluoroquinolone class, offering broad‑spectrum activity against Gram‑negative and some Gram‑positive bacteria. Compared with beta‑lactams, it provides excellent oral bioavailability and tissue penetration, often allowing once‑daily dosing. However, fluoroquinolones carry specific safety considerations such as tendon toxicity and QT prolongation, which may make other classes preferable in certain patient populations.

Levofloxacina Mylan Generics Italia should be stored at ambient temperature, below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture, heat, and direct sunlight. Do not store in bathrooms or near kitchen appliances that generate steam or high humidity.

Levofloxacina Mylan Generics Italia is supplied as oral tablets intended for systemic use. The tablets are taken with a full glass of water, with or without food, unless the prescriber advises otherwise. Patients should swallow the tablet whole and avoid crushing or chewing, as this can affect drug absorption.

Serious adverse events linked to levofloxacin include tendon rupture (particularly the Achilles tendon), QT interval prolongation leading to cardiac arrhythmias, severe hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome, and Clostridioides difficile‑associated diarrhea. Patients should be instructed to seek immediate medical attention if they experience sudden tendon pain, palpitations, rash, or severe gastrointestinal symptoms.

Levofloxacin is contraindicated in patients with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation. It should also be avoided in individuals with a history of tendon disorders related to fluoroquinolone use, uncontrolled arrhythmias, or those taking medications that significantly prolong the QT interval. The prescriber will assess suitability on an individual basis.